California Code, Health and Safety Code - HSC § 120115

(a) “Infectious tuberculosis disease” means active or suspected active tuberculosis disease in an infectious state.

(b) “Tuberculosis infection” means the latent phase of tuberculosis, during which the infected person cannot spread tuberculosis to others.

(c) “Heightened risk of tuberculosis exposure” means likely exposure to persons with infectious tuberculosis disease.

(d) “The appropriate prescribed course of medication for tuberculosis disease” means that course recommended by the health officer, the most recent guidelines of the department, the most recent guidelines of the Centers for Disease Control and Prevention, or the most recent guidelines of the American Thoracic Society.

(e) “Directly observed therapy” means the appropriately prescribed course of treatment for tuberculosis disease in which the prescribed antituberculosis medications are administered to the person or taken by the person under direct observation of a health care provider or a designee of the health care provider approved by the local health officer.

(f) An “examination” for tuberculosis infection or disease means conducting tests, including, but not limited to, Mantoux tuberculin skin tests, laboratory examination, and X-rays, as recommended by any of the following:

(g) “State correctional institution” means a prison, institution, or other facility under the jurisdiction of the Department of Corrections or the Department of the Youth Authority.

(h) “Local detention facility” is defined in Section 6031.4 of the Penal Code.

(i) “Penal institution” means either a state correctional institution or a local detention facility.

(j) “Health facility” means a licensed health facility as defined in Sections 1250, 1250.2, and 1250.3.

(k) “Health officer” or “local health officer” includes his or her designee.